- CA$959.05m
- CA$1.53bn
- $188.92m
CTI Biopharma surges after FDA approves bone marrow drug
Brief: DRI Healthcare Trust Comments On FDA Approval Of Vonjotm (Pacritinib)
Brief: DRI Healthcare Trust Declares Special Distributions
Brief: Dri Healthcare Trust Says Approval Of Pacritinib By FDA Is Condition To Acquisition Of Tiered Royalty On Pacritinib
Canada Research Roundup: Agnico Eagle Mines, Sierra Metals, WSP Global
Brief: DRI Healthcare Trust Reports Increase To Quarterly Distribution
Brief: Dri Healthcare Trust Announces Us$200 Million Credit Facility
Brief: DRI Healthcare Acquires Royalty Interest In Oracea For $46.4 Mln
CTI BioPharma rises on funding for launch of cancer drug
Brief: CTI Biopharma And DRI Healthcare Announce Up To $135 Mln Transaction
Brief: Dri Healthcare Quarterly Earnings Per Unit $0.18
Brief: DRI Healthcare Trust Reports Q1 Adjusted Cash Earnings Per Unit Of $0.54
Brief: DRI Healthcare Trust Announces Pricing Of IPO Of Trust Units